Health Care

Former Acting White House Chief of Staff Mick Mulvaney said on Friday that legislation is needed to "dramatically" change U.S. health care.

The insurance giant is accused of practices that allegedly limited competition.

AstraZeneca says it's still waiting on federal approval to resume the U.S. clinical trial of its COVID-19 vaccine candidate nearly three weeks after the study was halted over safety concerns.

J&J is making innovative strides with Phase 3 trials of a single-shot COVID-19 vaccine.

GoodRx Holdings Inc on Tuesday priced its initial public offering higher than anticpated

The U.S. retailer has partnered with Quest Diagnostics and drone services provider DroneUp, to test-deliver collection kits in north Las Vegas from Tuesday and plans to conduct a trial run in Cheektowaga, New York in early October.

The program does not cover drugs approved for emergency use.

Democratic presidential nominee Joe Biden used the sudden Supreme Court vacancy to reinforce his argument that the upcoming election should be a referendum on President Donald Trump's handling of health care and the coronavirus.

Patients who received the drugs were 44% less likely to progress to the point where they would need to rely on ventilation.

Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run.

New York State has filed civil charges against Johnson & Johnson and its Janssen Pharmaceuticals subsidiaries on insurance fraud for minimizing the risks of opioid treatment and targeting the most vulnerable population. 

Eli Lilly CEO David Ricks told FOX Business on Wednesday that the results of a mid-stage clinical trial assessing the drugmaker's experimental antibody treatment reduced the rate of hospitalization in COVID-19 patients.

Pfizer Inc said on Tuesday participants were showing mostly mild-to-moderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing late-stage study.

“We don’t have all facts, so we don’t know the causation per se of this, but we really need to look into it," FDA Commissioner Stephen Hahn said.

The company that runs New York Sports Club and Lucille Roberts gyms filed for bankruptcy protection on Monday, as business and memberships decline at gyms in parts of the nation still grapple with the novel coronavirus pandemic.

Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the companies said on Sunday in a statement.

While Bourla acknowledged the possibility Pfizer's vaccine candidate could fail, he argued that he doesn't believe any potential financial hit will "break the company" despite investing at least $1.5 billion in the effort.

Pfizer and BioNTech reiterated that results from their vaccine candidate's late-stage trial could be available as early as October.